Abstract
Amylin is the major component of the amyloid found in the pancreases of noninsulin-dependent diabetics (type 2 diabetes). It is a 37 amino acid polypeptide and has been shown to have 46% sequence identity with the neuropeptide α-calcitonin gene-related peptide (α-CGRP). Both amylin and α-CGRP are known to be potent inhibitors of glycogen synthesis in stripped rat soleus muscle. Secondary structure prediction and tertiary structure model-building show the two polypeptides to have an α-helix/β-strand motif similar to that observed in the insulin B-chain. The results have been supported by CD spectroscopy, although there is no sequence similarity between insulin and amylin/α-CGRP. Aggregation states have been predicted based on the dimeric and hexameric arrangements seen in porcine insulin. Rat and hamster amylin have a changed sequence motif in the β-strand which results in lack of amyloid formation and type 2 diabetes. This, we propose, is caused by disruption of hydrogen bonding which prevents the formation of the dimer.
Original language | English (US) |
---|---|
Pages (from-to) | 539-544 |
Number of pages | 6 |
Journal | Protein Engineering, Design and Selection |
Volume | 4 |
Issue number | 5 |
DOIs | |
State | Published - Jun 1991 |
Externally published | Yes |
Keywords
- Amylin
- Model-building
- PROLOG
- Structure prediction
- α-CGRP
ASJC Scopus subject areas
- Bioengineering
- Molecular Biology
- Biochemistry
- Biotechnology